Risperidone for the treatment of fecal smearing in a developmentally disabled adult.
OBJECTIVE
The use of risperidone in decreasing fecal smearing behavior as an expression of nonverbal aggression in a developmentally disabled adult is discussed.


CONCLUSIONS
A 36-year-old Caucasian man had a history of fecal smearing when he did not get his way or was upset. The patient had profound mental retardation, had an IQ in the range of less than 20 to 25, and was nonverbal. For this patient, fecal smearing was not only a behavioral issue but also a medical concern because he was hepatitis B positive with noncarrier status. Serology also confirmed previous infection with hepatitis A. Risperidone was started at 0.5 mg twice daily. Smearing frequencies during baseline and after risperidone intervention were tracked. During the course of treatment, the risperidone dosage was increased to a total daily dose of 4 mg. The mean +/- S.D. number of episodes per month decreased from 15.2 +/- 3 in the pretreatment period to 6.0 +/- 1.8 at 6 months and 6.7 +/- 1.2 at 12 months posttreatment with risperidone. On follow-up in October 2003, fecal smearing had further decreased to the point where it was no longer formally tracked. A diagnosis of mental retardation, developmental disability, or pervasive developmental disorder increases the possibility for emotional and behavioral problems. Previous medication classes tried in the management of aggressive behaviors have not produced consistent results. Risperidone has been used in the treatment of self-abuse, aggression toward others, and violent behaviors.


CONCLUSIONS
Risperidone was effective in decreasing episodes of fecal smearing as an expression of nonverbal aggression in a developmentally disabled adult.
Brahm
Nancy C
NC
Department of Pharmacy Practice, University of Oklahom, Tulsa, OK 74135-2512, USA. nancy-brahm@ouhsc.edu
Farmer
Kevin C
KC
Brown
Robert C
RC
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D032763:Behavior Control / Q000379:methods*; D006233:Persons with Disabilities; D005243:Feces; D006509:Hepatitis B / Q000150:complications; D006801:Humans; D008607:Intellectual Disability / Q000150:complications / Q000188:drug therapy*; D008297:Male; D018967:Risperidone / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D018967:Risperidone